# FDA Warning Letter: Pharmacy2Home/LandiCom Holding LTD
> 2022-02-15 · Center for Drug Evaluation and Research | CDER · `78af2f99d71e7a93`
## Letter
- **Company:** Pharmacy2Home/LandiCom Holding LTD
- **Posted Date:** 2022-02-15
- **Letter Issue Date:** 2022-02-03
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*